In Vitro Characterization of a Sustained-Release Formulation for Enfuvirtide

被引：10
|
作者：
Rothstein, Sam N. [1 ]
Huber, Kelly D. [2 ]
Siuis-Cremer, Nicolas [2 ]
Little, Steven R. [1 ,3 ,4 ,5 ,6 ]
机构：
[1] Qrono Inc, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA
[6] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2014年 / 58卷 / 03期
关键词：
ERODING POLYMER MATRICES; PREDICTION; HIV-1; MODEL;
D O I：
10.1128/AAC.02440-13
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Although approved by the U.S. Food and Drug Administration, enfuvirtide is rarely used in combination antiretroviral therapies (cART) to treat HIV-1 infection, primarily because of its intense dosing schedule that requires twice-daily subcutaneous injection. Here, we describe the development of enfuvirtide-loaded, degradable poly(lactic-co-glycolic) acid microparticles that provide linear in vitro release of the drug over an 18-day period. This sustained-release formulation could make enfuvirtide more attractive for use in cART.
引用
收藏
页码：1797 / 1799
页数：3
相关论文
共 50 条
  • [1] FORMULATION AND IN-VITRO CHARACTERIZATION OF AMBROXOL HYDROCHLORIDE SUSTAINED-RELEASE MATRIX TABLETS
    Jaya, S.
    Srilaxmi, G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (03): : 1208 - 1213
  • [2] In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation
    Puri, V
    Bansal, AK
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (06) : 619 - 626
  • [3] Bioavailability of a generic sustained-release formulation of diclofenac compared with the standard sustained-release formulation
    Hooper, IT
    Allen, E
    McLaughlin, K
    Ward, C
    Sioufi, A
    CLINICAL DRUG INVESTIGATION, 1996, 12 (05) : 259 - 270
  • [4] FORMULATION OF TABLETS WITH SUSTAINED-RELEASE
    SALOMON, JL
    DOELKER, E
    PHARMACEUTICA ACTA HELVETIAE, 1980, 55 (06): : 174 - 182
  • [5] Development of Sustained-Release Microbeads of Nifedipine and In vitro Characterization
    Bashir, Sajid
    Asad, Muhammad
    Qamar, Sumbul
    ul Hassnain, Fakhar
    Karim, Sabiha
    Nazir, Imran
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (04) : 505 - 510
  • [6] Buprenorphine loaded PLGA microparticles: Characterization of a sustained-release formulation
    Schreiner, Viktoria
    Detampel, Pascal
    Jirkof, Paulin
    Puchkov, Maxim
    Huwyler, Jorg
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 63
  • [7] A research on aspirin sustained-release formulation
    Xu, GJ
    Fang, F
    Zhang, RH
    Sunada, H
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (08) : 741 - 747
  • [8] Design, Formulation and In Vitro Evaluation of Sustained-release Tablet Formulations of Levosulpiride
    Samie, Muhammad
    Bashir, Sajid
    Abbas, Jabbar
    Khan, Samiullah
    Aman, Nargis
    Jan, Habibullah
    Muhammad, Naveed
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 15 (03) : 309 - 318
  • [9] Sustained-release formulation of sarpogrelate hydrochloride
    Hye Jin Kim
    Dae Hwan Shin
    Eun Ah Lim
    Jin-Seok Kim
    Archives of Pharmacal Research, 2015, 38 : 35 - 41
  • [10] SUSTAINED-RELEASE FORMULATION OF SALBUTAMOL SULFATE
    MURTHY, RSR
    MALHOTRA, M
    MIGLANI, BD
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (10) : 1373 - 1380
12345